(Principal Investigators are listed in alphabetical order by last name) Principal Investigator Institution Project Title/Research Areas Animesh Barua, Ph.D. Rush University Medical Center Early Detection of Ovarian Cancer by Serum Marker and Targeted Ultrasound Imaging Laura Beretta, Ph.D. University of Texas MD Anderson Cancer Center Early Detection of Hepatocellular Carcinoma Matthew Conklin, Ph.D. University of Wisconsin-Madison Collagen Structural Changes as an Early Biomarker for Breast Carcinoma Paul A. Dayton, Ph.D. University of North Carolina, Chapel Hill Improving Breast Ultrasound Specificity through SFRP2-targeted Molecular Imaging Randa A. El-Zein, M.B.Ch.B., Ph.D. Houston Methodist Research Institute Integrative Molecular and Imaging Approaches for Risk of Subtype Specific Breast Paul Lampe, Ph.D. Fred Hutchinson Cancer Research Center Hybrid Plasma Markers that Complement CT Imaging for Early Lung Cancer Detection Marc E. Lenburg, Ph.D. Boston University Medical Campus Molecular and Imaging Biomarkers for Early Lung Cancer Detection in the Setting of Intermediate Pulmonary Nodules Jason Lewis, Ph.D. Memorial Sloan Kettering Cancer Center Pretargeted Clinical Imaging of CA19.9 in Pancreatic Cancer Pierre P. Massion, M.D. Vanderbilt University Non-invasive Evaluation of Indeterminate Pulmonary Nodules Alan Pollack, M.D., Ph.D. University of Miami School of Medicine MRI Imaging and Genetic Signatures to Manage Prostate Cancer Overdianosis Rebecca Richards-Kortum, Ph.D. Rice University High Resolution Imaging & HPV Oncoprotein Detection for Global Prevention of Cervical Cancer Victoria L. Seewaldt, M.D. Duke University/Beckman Research Institute Combined Breast MRI/Biomarker Strategies to Identify Agressive Biology Eric J. Seibel, Ph.D. University of Washington Multiplexed Imaging of Biliary Intra-epithelial Neoplasia Ayumu Taguchi, M.D., Ph.D. University of Texas MD Anderson Cancer Center Blood Biomarkers for Lung Cancer Screening Risk Assessment and Early Detection Daniel B. Vigneron, Ph.D. University of California, San Francisco Hyperpolarized C-13 MRI for Early Detection of Aggressive Prostate Cancer in Active Surveillance Patients Thomas D. Wang, M.D., Ph.D. University of Michigan Multiplexed Multi-modal Endoscopic Imaging of Cancer Biomarkers Jun Wei, Ph.D. University of Michigan Quantitative Parenchyma Descriptor as an Imaging Biomarker of Breast Cancer Risk Chuan Zhou, Ph.D. University of Michigan Histopathology Correlated Quantitative Analysis of Lung Nodules with LDCT for Early Detection of Lung Cancer
